Forteo 560 MCG/2.24 ML pen INJ 2.24ML
Ended Awarded
- Contract number
- SPE2DB25FWZZR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,333
Award facts
- Contract value 100% obligated
- $7,333.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Forteo 560 MCG/2.24 ML pen injections valued at $7,333.28. This is a firm fixed price delivery order with an ultimate completion date of September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was not made under any small business set-aside program and was competitively awarded. Forteo is a prescription medication used in the treatment of osteoporosis and bone disorders, representing the type of specialized pharmaceutical products that AmerisourceBergen regularly supplies to federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle valid through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for the Defense Health Agency and other federal healthcare programs, with this IDC enabling the company to furnish a wide range of brand-name and generic medications, specialty drugs, vaccines, and medical supplies to support military healthcare operations globally. The company's extensive portfolio of federal awards demonstrates its established capability to meet federal procurement requirements for complex pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FWZZR?
SPE2DB25FWZZR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FWZZR worth?
The government has obligated $7,333 on SPE2DB25FWZZR.
Is contract SPE2DB25FWZZR an order under another contract?
Yes. SPE2DB25FWZZR is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWZZR competed?
The extent of competition for SPE2DB25FWZZR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award